On June 13, 2023, Innolake Biopharm was announced as the winner of "Top 10 Biopharmaceutical Companies with the Highest Growth Potential Award" for its multi-dimensional innovation and high-speed development at the awarding ceremony of "BIO-FORUM 2023" and “2023 China Biomedical Science and Technology Innovation Value List” held in Shanghai. Dr. Mingde Xia, the chairman and CEO of Innolake Biopharm, was granted the "Eternal Enlightenment " award for his achievement as a scientist-entrepreneur together with other two industry leaders.

About "2023 China Biomedical Science and Technology Innovation Value List”

To evaluate the innovation of all company candidates, the "2023 China Biomedical Science and Technology Innovation Value List" covers 12 biomedical categories, including small molecule drugs, biologic drugs, traditional Chinese medicine, vaccines, cell gene therapy, innovative devices, in-vitro diagnostics, etc. Based on the strict scoring criteria combined with questionnaire survey, interviews, data analysis and verification, the winners of innovation value award are finally selected out of 30,000+ enterprises and organizations. The 2023 innovation value list will guide the future development path of China biopharmaceutical innovation.